ROCO
4735
Market cap38mUSD
Nov 12, Last price
33.00TWD
Name
Avita Corp
Chart & Performance
P/E
20.87
P/S
1.30
EPS
1.58
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
3.37%
Revenues
927m
+5.48%
Net income
58m
+35.49%
CFO
193m
-9.20%
Dividend
Aug 31, 20230.5 TWD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
AViTA Corporation manufactures and sells home healthcare products. Its products include non-contact and infrared ear/forehead thermometers, arm and wrist type blood pressure monitors (BPM), electronic lice combs, and nasal aspirators, as well as as pulse oximeter, nebulizer, and tubeless arm BPM. The company was founded in 1996 and is headquartered in New Taipei City, Taiwan.
Valuation
Title TWD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | ||||||
Revenues | ||||||
Cost of revenue | ||||||
Unusual Expense (Income) | ||||||
NOPBT | ||||||
NOPBT Margin | ||||||
Operating Taxes | ||||||
Tax Rate | ||||||
NOPAT | ||||||
Net income | ||||||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | ||||||
BB yield | ||||||
| Debt | ||||||
Debt current | ||||||
Long-term debt | ||||||
Deferred revenue | ||||||
Other long-term liabilities | ||||||
Net debt | ||||||
| Cash flow | ||||||
Cash from operating activities | ||||||
CAPEX | ||||||
Cash from investing activities | ||||||
Cash from financing activities | ||||||
FCF | ||||||
| Balance | ||||||
Cash | ||||||
Long term investments | ||||||
Excess cash | ||||||
Stockholders' equity | ||||||
Invested Capital | ||||||
ROIC | ||||||
ROCE | ||||||
| EV | ||||||
Common stock shares outstanding | ||||||
Price | ||||||
Market cap | ||||||
EV | ||||||
EBITDA | ||||||
EV/EBITDA | ||||||
Interest | ||||||
Interest/NOPBT | ||||||